GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

October 01, 2017 (Vol. 37, No. 17)

Bending the Cost and Time Curve of Drug Development through the Use of Biomarkers

  • The right biomarker can make all the difference in a drug-development program, allowing a clinical trial to enroll a smaller patient population, lowering costs, and shortening timelines. As much as the right biomarker might be desired, it might not exist. It might need to be discovered and developed. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.